Literature DB >> 22541658

Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters.

Won Ki Lee1, Kyu Seop Kim, Wungjae Kim, Seung Bum Lee, Sohee Jeon.   

Abstract

PURPOSE: To investigate the responses to photodynamic therapy (PDT) in patients with polypoidal choroidal vasculopathy (PCV) that show large aneurysmal dilation with internal angio-architecture consisting of diverse patterns of curvilinear vessels and polyps resembling grape clusters.
DESIGN: Retrospective, interventional case series.
METHODS: Twenty-two eyes of 22 patients were included. All patients initially received PDT monotreatment. The main outcome measures were the rates of complete polyp regression on indocyanine green angiography and initial favorable responses observed clinically. Also, the rates of recurrent exudative changes were evaluated at the 2-year follow-up. We focused on changes in the vascular features and their clinical association.
RESULTS: Complete regression of polypoidal lesions was observed in 21 eyes (95%) after a mean of 1.7 PDTs. However, favorable clinical responses were achieved in only 9 eyes (41%), and 6 of them had recurrent exudation. Main vessels, previously consisting of the polypoidal lesion frame, persisted. Additionally, aberrant vessels with a thin radiating or tortuous configuration were observed in the area where large aneurysmal dilation was present. Leakage from this vascular complex or an expanded vascular complex was observed in a total of 14 eyes (64%) during the 2-year follow-up, contributing to persistent (8 eyes) or recurrent (6 eyes) exudation. This seemed to represent secondary choroidal neovascularization (CNV). In another 4 eyes (18%), fibrous changes developed immediately after PDT. Polyps recurred in 8 eyes (38%).
CONCLUSIONS: This PCV pattern frequently evolved into typical CNV after PDT, resulting in persistent or recurrent exudation despite the disappearance of polypoidal structures.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541658     DOI: 10.1016/j.ajo.2012.02.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.

Authors:  M Inoue; A Arakawa; S Yamane; K Kadonosono
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

2.  Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy.

Authors:  J H Kim; Y S Chang; J W Kim; C G Kim; D W Lee
Journal:  Eye (Lond)       Date:  2017-07-14       Impact factor: 3.775

Review 3.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

4.  Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial.

Authors:  Won Ki Lee; Tomohiro Iida; Yuichiro Ogura; Shih-Jen Chen; Tien Yin Wong; Paul Mitchell; Gemmy Chui Ming Cheung; Zhongqi Zhang; Sérgio Leal; Tatsuro Ishibashi
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

5.  Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters.

Authors:  Jae Hyung Lee; Won Ki Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-03       Impact factor: 3.117

6.  Factors associated with polyp regression after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.

Authors:  Han Joo Cho; Sang Yoon Han; Hyoung Seok Kim; Tae Gon Lee; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2014-11-07       Impact factor: 2.447

7.  The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients.

Authors:  Chui Ming Gemmy Cheung; Elizabeth Yang; Won Ki Lee; Gary K Y Lee; Ranjana Mathur; Jacob Cheng; Doric Wong; Tien Yin Wong; Timothy Y Y Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-27       Impact factor: 3.117

8.  Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy.

Authors:  Wen-Yi Wang; Chang-Hao Yang; Ta-Ching Chen; Yi-Ting Hsieh; Tzyy-Chang Ho; Chung-May Yang; Fang-Yu Liu; Tso-Ting Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-08       Impact factor: 3.117

Review 9.  Pachychoroid disease.

Authors:  Chui Ming Gemmy Cheung; Won Ki Lee; Hideki Koizumi; Kunal Dansingani; Timothy Y Y Lai; K Bailey Freund
Journal:  Eye (Lond)       Date:  2018-07-11       Impact factor: 3.775

10.  Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy.

Authors:  Chinmayi Himanshuroy Vyas; Chui Ming Gemmy Cheung; Colin Tan; Caroline Chee; Kelly Wong; Janice Marie N Jordan-Yu; Tien Yin Wong; Anna Tan; Beau Fenner; Shaun Sim; Kelvin Yi Chong Teo
Journal:  BMJ Open       Date:  2021-07-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.